A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

This publication has 38 references indexed in Scilit:

• The randomization and stratification of patients to clinical trials
  Published by Elsevier ,2004
• Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Randomized phase trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-09
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Designing clinical trials for two-sided multiple comparisons with a control
  Controlled Clinical Trials, 1989
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
  The Annals of Statistics, 1988
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958
• A Multiple Comparison Procedure for Comparing Several Treatments with a Control
  Journal of the American Statistical Association, 1955